New England Journal of Medicine

Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

M Melanie J. Davies H Harpreet S. Bajaj (Endocrine and Metabolic Research, LMC Healthcare, Brampton, ON, Canada) C Christa Broholm (Novo Nordisk, Søborg, Denmark) A Astrid Eliasen (Novo Nordisk, Søborg, Denmark) W W. Timothy Garvey (Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham) C Carel W. le Roux (University College Dublin School of Medicine, Dublin) I Ildiko Lingvay (Department of Internal Medicine and Endocrinology, University of Texas Southwestern Medical Center, Dallas) C Christian Bøge Lyndgaard (Novo Nordisk, Søborg, Denmark) J Julio Rosenstock (Velocity Clinical Research Center at Medical City Dallas, Dallas) S Sue D. Pedersen (C-ENDO Diabetes and Endocrinology Clinic, Calgary, AB, Canada)
Download PDF View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 393, Issue 7
Published August 14, 2025
Pages 648-659
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences

Authors (10)

M

Melanie J. Davies

H

Harpreet S. Bajaj

Endocrine and Metabolic Research, LMC Healthcare, Brampton, ON, Canada

C

Christa Broholm

Novo Nordisk, Søborg, Denmark

A

Astrid Eliasen

Novo Nordisk, Søborg, Denmark

W

W. Timothy Garvey

Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham

C

Carel W. le Roux

University College Dublin School of Medicine, Dublin

I

Ildiko Lingvay

Department of Internal Medicine and Endocrinology, University of Texas Southwestern Medical Center, Dallas

C

Christian Bøge Lyndgaard

Novo Nordisk, Søborg, Denmark

J

Julio Rosenstock

Velocity Clinical Research Center at Medical City Dallas, Dallas

S

Sue D. Pedersen

C-ENDO Diabetes and Endocrinology Clinic, Calgary, AB, Canada

Related Articles from this Journal

Doctor’s Dirty Little Secret — The Cost of Silence

Tara Khan Aug 2026 10.1056/nejmp2515506

Obstructive Hypertrophic Cardiomyopathy

Julian-Kai Nishizono, Marohito Nakata Aug 2026 10.1056/nejmicm2603868

T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation

Martina Schatzl, Katharina A. Mayer et al. Jul 2026 10.1056/nejmc2603853

Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?

Jerry Avorn Jul 2026 10.1056/nejmp2604841

Precision Intensification in Metastatic Prostate Cancer

Rana R. McKay Jul 2026 10.1056/nejme2605582